Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Approach to Hypertrophic Cardiomyopathy.

Autore C, Spirito P, Spirito P.

Curr Treat Options Cardiovasc Med. 2004 Dec;6(6):489-498.

PMID:
15496266
2.

Management of hypertrophic cardiomyopathy in children.

Seggewiss H, Rigopoulos A.

Paediatr Drugs. 2003;5(10):663-72. Review.

PMID:
14510624
3.

[Interventional treatment in hypertrophic cardiomyopathy].

Gietzen FH, Schümmelfeder J, Neuser H, Brunn J, Schumacher B, Kerber S.

Herz. 2005 Mar;30(2):102-10. Review. German.

PMID:
15875098
4.

[Risk stratification for sudden death in hypertrophic cardiomyopathy].

Spirito P, Maron BJ.

Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Apr;37(4):294-7. Chinese.

PMID:
19791461
5.

Risk stratification and prevention of sudden death in hypertrophic cardiomyopathy.

Autore C, Quarta G, Spirito P.

Curr Treat Options Cardiovasc Med. 2007 Dec;9(6):431-5.

PMID:
18221594
6.

Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.

Vieira AP, Adragão PP, Santos KR, Morgado FB, Cavaco DM, Rossi R, Abecasis M, Neves JP, Bonhosrst D, Gomes JL, Gomes RS.

Rev Port Cardiol. 2005 Mar;24(3):407-15. English, Portuguese.

PMID:
15929624
7.

Hypertrophic Cardiomyopathy.

Behr ER, McKenna WJ.

Curr Treat Options Cardiovasc Med. 2002 Dec;4(6):443-453.

PMID:
12408787
8.

Sudden death and hypertrophic cardiomyopathy: a review.

Ly HQ, Greiss I, Talakic M, Guerra PG, Macle L, Thibault B, Dubuc M, Roy D.

Can J Cardiol. 2005 Apr;21(5):441-8. Review.

PMID:
15861263
9.

Syncope, other risk factors, and the implantable defibrillator for sudden death prevention in hypertrophic cardiomyopathy.

Cotiga D, Ehlert F, Sherrid M.

Anadolu Kardiyol Derg. 2006 Dec;6 Suppl 2:55-60. Review.

10.

[The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].

Marín F, Gimeno JR, Payá E, García-Alberola A, Pérez-Alvarez L, Fernández X, de la Morena G, Sogorb F, Castro-Beiras A, Valdés M, Martínez JG, Monserrat L.

Rev Esp Cardiol. 2006 Jun;59(6):537-44. Spanish.

11.

Transcoronary ablation of septal hypertrophy does not alter ICD intervention rates in high risk patients with hypertrophic obstructive cardiomyopathy.

Lawrenz T, Obergassel L, Lieder F, Leuner C, Strunk-Mueller C, Meyer Zu Vilsendorf D, Beer G, Kuhn H.

Pacing Clin Electrophysiol. 2005 Apr;28(4):295-300.

PMID:
15826262
12.

Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy.

Maron BJ, Spirito P.

J Cardiovasc Electrophysiol. 2008 Oct;19(10):1118-26. doi: 10.1111/j.1540-8167.2008.01147.x. Epub 2008 Mar 31. Review.

PMID:
18384577
13.

Risk stratification in hypertrophic cardiomyopathy.

Vassalli G, Seiler C, Hess OM.

Curr Opin Cardiol. 1994 May;9(3):330-6. Review.

PMID:
8049590
14.

Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers.

Christiaans I, van Engelen K, van Langen IM, Birnie E, Bonsel GJ, Elliott PM, Wilde AA.

Europace. 2010 Mar;12(3):313-21. doi: 10.1093/europace/eup431. Epub 2010 Jan 29. Review.

PMID:
20118111
15.

Episodic syncope in hypertrophic cardiomyopathy: evidence for inappropriate vasodilation.

Prasad K, Williams L, Campbell R, Elliott PM, McKenna WJ, Frenneaux M.

Heart. 2008 Oct;94(10):1312-7. doi: 10.1136/hrt.2008.141507. Epub 2008 Jul 24.

PMID:
18653581
16.

Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy.

McLeod CJ, Ommen SR, Ackerman MJ, Weivoda PL, Shen WK, Dearani JA, Schaff HV, Tajik AJ, Gersh BJ.

Eur Heart J. 2007 Nov;28(21):2583-8. Epub 2007 May 4.

PMID:
17483110
17.

Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.

Limongelli G, Elliott PM, Pacileo G, Sarubbi B, Thaman R, Calabrò P, Vergara P, Iacomino M, Russo MG, Calabrò R.

J Cardiovasc Med (Hagerstown). 2006 Sep;7(9):711-3.

PMID:
16932087
18.

[Hypertrophic cardiomyopathy and sudden death].

Piccininno M, Spirito P.

Recenti Prog Med. 2001 Mar;92(3):205-8. Review. Italian.

PMID:
11320853
19.

[Hypertrophic cardiomyopathy: current aspects and new developments].

Desnos M.

Bull Acad Natl Med. 2012 Apr-May;196(4-5):997-1009; discussion 1009-10. French.

PMID:
23550458
20.

Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?

Wichter T, Paul TM, Eckardt L, Gerdes P, Kirchhof P, Böcker D, Breithardt G.

Herz. 2005 Mar;30(2):91-101. Review.

PMID:
15875097

Supplemental Content

Support Center